Cardiovascular Devices Market – Trends Forecast Till 2031

Market Snapshot

Market Overview

The Global Cardiovascular Devices Market size was estimated at USD 59,065.9 million in 2024 and is projected to reach USD 109,369.3 million in 2031 at a CAGR of 9.2% during the forecast period 2025-2031.

The cardiovascular devices market refers to the industry involved in the manufacturing, distribution, and innovation of medical devices used in the diagnosis, treatment, and prevention of cardiovascular diseases (CVDs). This market includes a wide range of products such as stents, pacemakers, heart valves, defibrillators, catheters, and diagnostic imaging devices. As cardiovascular diseases remain one of the leading causes of death worldwide, the demand for effective and advanced medical solutions has driven the growth of this market. The market is heavily influenced by technological advancements, rising awareness of heart-related diseases, and the increasing prevalence of risk factors such as hypertension, diabetes, and obesity.

The scope of the cardiovascular devices market extends across a variety of applications, including diagnostics, treatment, and monitoring of heart conditions. These devices are used in both surgical and non-surgical procedures, helping physicians to diagnose issues like coronary artery disease, heart failure, arrhythmias, and valve disorders. Furthermore, devices such as pacemakers and defibrillators are essential for managing and stabilizing patients with irregular heart rhythms. The scope also involves a strong focus on the development of minimally invasive devices, as these offer quicker recovery times and reduced risks compared to traditional surgery. The market covers a broad geographic reach, with key regions such as North America, Europe, and Asia-Pacific playing a crucial role in driving demand and innovation.

Recent trends in the cardiovascular devices market include the integration of advanced technologies like artificial intelligence (AI), robotics, and 3D printing into device development. These innovations are contributing to the creation of more precise, efficient, and personalized cardiovascular treatments. There is also a notable trend towards the development of bioresorbable devices, which offer the potential for reduced complications and eliminate the need for long-term implantation. Furthermore, a growing emphasis on preventive care and remote monitoring devices is helping to shift focus towards the management and early detection of cardiovascular conditions before they require surgical intervention. Telemedicine and digital health platforms are also gaining traction, allowing for continuous monitoring of patients’ cardiovascular health.

Key drivers of the cardiovascular devices market include the aging global population, increasing urbanization, and the rise in lifestyle-related diseases, which are contributing to a higher incidence of cardiovascular conditions. Additionally, advancements in healthcare infrastructure and the availability of better reimbursement policies in various countries are supporting market growth. Growing awareness campaigns aimed at educating the public about heart health and the increasing adoption of advanced treatment protocols are also driving the demand for cardiovascular devices. Moreover, government initiatives focused on reducing the global burden of heart diseases are encouraging research and development, thus propelling the market further.

Delvens Industry Expert's Standpoint

Experts in the Global Cardiovascular Devices Market highlight several key trends driving growth and innovation. The global cardiovascular devices market encompasses a wide range of medical devices used in diagnosing, treating, and preventing cardiovascular diseases, including stents, pacemakers, heart valves, and defibrillators. Driven by an aging population, increasing prevalence of lifestyle-related risk factors, and technological advancements, the market is expanding with innovations like AI, robotics, and bioresorbable devices. Trends in minimally invasive treatments and remote monitoring are transforming care delivery, while growing awareness of heart health and better healthcare infrastructure are further boosting market growth. Key drivers also include improved reimbursement policies, government initiatives, and the rising global burden of cardiovascular diseases.

Market Portfolio

Key Findings

• In terms of product segments, the market is divided into diagnostic & monitoring devices and surgical devices. The surgical devices segment, which includes products like cardiac resynchronization therapy devices, pacemakers, coronary stents, and valves, currently holds the largest revenue share. This growth is driven by an increasing number of companies introducing new products, such as Abbott's launch of the XIENCE Sierra Everolimus-Eluting Coronary Stent System in India. On the other hand, the diagnostic and monitoring devices segment is expected to experience the fastest growth due to rising demand for devices like ECGs, particularly in-home healthcare. The growing prevalence of cardiovascular diseases and advancements in wireless ECG technology, which enables real-time monitoring, are key factors driving this segment's expansion.

• The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America region is projected to hold the largest market share. Factors such as rising prevalence of cardiovascular diseases, aging population, demand for minimally invasive procedures, technological advancements, improved healthcare infrastructure, increased awareness, favorable reimbursement policies, lifestyle risk factors, advancements in personalized medicine, and regulatory support have triggered the Global Cardiovascular Devices Market in the region.

Regional Analysis

North America to Dominate the Market

• North America dominates the cardiovascular devices market, holding the largest revenue share, driven by the rising prevalence of Atrial Fibrillation (AFib) and cardiovascular diseases (CVD), strong government initiatives, and technological advancements. The U.S. benefits from a high burden of CVD, prompting increased demand for advanced treatment solutions, while Canada’s growth is supported by government investments and national research networks aimed at enhancing cardiovascular care.

• In Europe, the market is experiencing significant growth due to the high mortality rates from CVDs, which remain the leading cause of death in the region. Countries like the UK, Germany, and France are witnessing a rise in demand for cardiovascular devices due to increasing CVD-related deaths and the need for better treatment options. Regulatory support, such as CE mark approvals, and healthcare innovations further fuel the market’s expansion across European nations.

• The Asia Pacific region is poised for rapid growth, driven by the aging population and increasing demand for advanced medical devices. China’s market is expanding with the rising demand for high-quality cardiac care, while Japan is seeing growth due to technological advancements in AI and wearable devices. India’s market is also growing due to collaborations that improve the availability of cardiovascular devices, driving adoption and improving patient outcomes.

• In Latin America, the market is growing due to the rising incidence of CVDs and technological advancements. Brazil’s market is benefiting from increased healthcare expenditures and government initiatives to enhance cardiac care infrastructure. In countries like Mexico, there is a notable demand for innovative diagnostic and treatment devices, fueled by growing healthcare access and improved medical infrastructure.

• The Middle East and Africa (MEA) region is witnessing growth in the cardiovascular devices market, driven by rising CVD prevalence, including cardiac arrhythmias like AFib. Saudi Arabia and Kuwait are leading the way, with the growing demand for CVD treatments supported by government initiatives to improve healthcare infrastructure, providing better access to innovative medical devices for the treatment and management of cardiovascular conditions.

Competitive Landscape

• Abbott
• GE HealthCare
• Edwards Lifesciences Corporation
• W. L. Gore & Associates, Inc.
• Siemens Healthcare GmbH
• BIOTRONIK SE & Co. KG
• Canon Medical Systems Asia Pte. Ltd.
• B. Braun SE
• LivaNova PLC
• Cardinal Health
• Medtronic
• Boston Scientific Corporation

Recent Developments

• In October 2024, Koninklijke Philips N.V. showcased its innovative cardiology solutions at the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting. These advancements were designed to boost clinical confidence, improve procedural efficiency, and enhance patient outcomes in interventional procedures, with the goal of providing better care to a broader patient population.

• In April 2024, Medtronic launched its latest breakthrough in cardiac surgery, the Avalus Ultra valve. This advanced surgical aortic tissue valve is designed to simplify implantation and optimize long-term patient management.

• In March 2024, Stryker unveiled the LIFEPAK CR2 AED and an Evacuation Chair for cardiac care. The LIFEPAK CR2 aids rescuers in delivering rapid CPR and shock during sudden cardiac arrest, featuring QUIK-STEP electrodes for quick placement and a Shock Advisory System for ECG analysis.

Reasons to Acquire

• Increase your understanding of the market for identifying the most suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors.
• Gain authentic and granular data access for the Global Cardiovascular Devices Market to understand the trends and the factors involved in changing market situations.
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.

Report Scope